Cognitive performance was not different among four classes of glucose-lowering medications for type 2 diabetes, data from the ...

Patients taking a GLP-1 for diabetes have a lower risk for AF at 3 years than those on other medications, report ...

A new study suggests that weight-loss drugs may significantly reduce alcohol consumption in people with obesity.

“Fructo-oligosaccharides (FOS) are prebiotic fibers that have a significant impact on the secretion and function of the natural hormone GLP-1, which plays a crucial role in glucose regulation, ...

First-generation GLP-1 weight-loss drugs can help reduce the risk of obesity-related cancers, new research shows. Liraglutide ...

The millions of people living with obesity need novel treatment options that are safe, effective and avoid the high costs and ...

Women often experience atypical cardiovascular symptoms and are at a higher risk for heart failure. Clinical studies have ...

From "Ozempic face" to "Ozempic mouth," rapid weight loss caused by these drugs has sparked a wave of unexpected side effects ...

A popular pharmaceutical intervention for weight loss may also have the potential to curb alcoholism, as researchers observed a “commonality of function.” Between those who swear by […] ...

In the realm of innovative health solutions, the HonXi SMGT-GLP-1 Nano Microneedle Patch stands out as a revolutionary approach to managing weight and controlling blood sugar levels. As the prevalence ...

The first clinical trial comparing semaglutide and tirzepatide, two popular, injectable weight-loss drugs, has been published ...